Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Melese Alemnew Ayal & Alemseged Beyene Berha. (2023) Comparative Safety and Changes in Immunologic and Virologic Parameters of Dolutegravir versus Efavirenz-Based Antiretroviral Therapies Among HIV Patients: A Retrospective Cohort Study. HIV/AIDS - Research and Palliative Care 15, pages 173-190.
Read now
Read now
Helena Rabie, Eric H. Decloedt, Anthony J. Garcia-Prats, Mark F. Cotton, Lisa Frigati, Marc Lallemant, Anneke Hesseling & H. Simon Schaaf. (2017) Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis. Expert Opinion on Pharmacotherapy 18:6, pages 589-598.
Read now
Read now
Frederic Crouzat, Anita C. Benoit, Colin Kovacs, Graham Smith, Nathan Taback, Ina Sandler, Megan Acsai, William Barrie, Jason Brunetta, Benny Chang, David Fletcher, David Knox, Barry Merkley, Malika Sharma, David Tilley & Mona Loutfy. (2016) Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles. HIV Clinical Trials 17:1, pages 1-11.
Read now
Read now
Fabrice Bailly & Philippe Cotelle. (2015) The preclinical discovery and development of dolutegravir for the treatment of HIV. Expert Opinion on Drug Discovery 10:11, pages 1243-1253.
Read now
Read now
Huda Taha, Archik Das & Satyajit Das. (2015) Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS. Infection and Drug Resistance 8, pages 339-352.
Read now
Read now
Articles from other publishers (9)
Ila M. Sarode & Anil B. Jindal. (2022) Current status of dolutegravir delivery systems for the treatment of HIV-1 infection. Journal of Drug Delivery Science and Technology 76, pages 103802.
Crossref
Crossref
Bluma Brenner, Ruxandra-Ilinca Ibanescu, Isabelle Hardy & Michel Roger. (2017) Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in “Real-World” Settings. Viruses 10:1, pages 10.
Crossref
Crossref
Leyuan Bao, Clare Hannon, Abimael Cruz-Mignoni, Denis Ptchelkine, Mei-yi Sun, Ami Miller, Wilawan Bunjobpol, Camilo E. Quevedo, Mariliza Derveni, Jennifer Chambers, Alison Simmons, Simon E. V. Phillips & Terence H. Rabbitts. (2017) Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein. Scientific Reports 7:1.
Crossref
Crossref
Bluma G. Brenner & Mark A. Wainberg. (2017) Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance. Virus Research 239, pages 1-9.
Crossref
Crossref
Mark G.J. de Boer, Guido E.L. van den Berk, Natasja van Holten, Josephine E. Oryszcyn, Willemien Dorama, Daoud ait Moha & Kees Brinkman. (2016) Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice. AIDS 30:18, pages 2831-2834.
Crossref
Crossref
Valeria Cozzi, Nitin Charbe, Sara Baldelli, Simone Castoldi, Chiara Atzori, Dario Cattaneo & Emilio Clementi. (2016) Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma. Therapeutic Drug Monitoring 38:3, pages 407-413.
Crossref
Crossref
Emmanuel Andre, Leila Belkhir, Léonie Goeminne, Alexandre Colmant, Jean-Yves Sottiaux, Halil Yildiz, Jean Ruelle, Michel Delmee, Bernard Vandercam & Jean-Philippe Defour. (2015) Immune reconstitution inflammatory syndrome due to Mycobacterium genavense in an HIV-infected patient: Impact of rapid species identification by rpoB sequencing on clinical management. JMM Case Reports 2:6.
Crossref
Crossref
Arun K. Ghosh, Cuthbert D. Martyr, Heather L. Osswald, Venkat Reddy Sheri, Luke A. Kassekert, Shujing Chen, Johnson Agniswamy, Yuan-Fang Wang, Hironori Hayashi, Manabu Aoki, Irene T. Weber & Hiroaki Mitsuya. (2015) Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein–Ligand X-ray Studies. Journal of Medicinal Chemistry 58:17, pages 6994-7006.
Crossref
Crossref
Duane P Grandgenett. (2015) Multifunctional facets of retrovirus integrase. World Journal of Biological Chemistry 6:3, pages 83.
Crossref
Crossref